Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where James C. Detter is active.

Publication


Featured researches published by James C. Detter.


Annals of Human Genetics | 1968

Inherited variations in human phosphohexose isomerase.

James C. Detter; Peter O. Ways; Eloise R. Giblett; Marjorie A. Baughan; D. A. Hopkinson; S. Povey; Harry Harris

1. The elctrophoretic pattern of phosphohexose isomerase has been examine in the blood of 3397 unrelated individuals from several different populations groups.


Science | 1969

6-Phosphogluconate Dehydrogenase: Hemizygous Manifestation in a Patient with Leukemia

Philip J. Fialkow; R. Lisker; James C. Detter; Eloise R. Giblett; C. Zavala

In a study of 41 patients with chronic myelocytic leukemia, two were found to have the 6-phosphogluconate dehydrogenase heterozygous phenotype A-B, and two had the phenotype characteristic of PdB homozygosity. Since one of the two with PdB homozygosity was the mother of two children with the A phenotype, it was presumed that she carried a PdA gene not expressed in her blood cells. his was confirmed by electrophoretic analysis of her fibroblasts, which had the A-B phenotypic pattern. Gene deletion is considered to be the most likely explanation.


American Journal of Obstetrics and Gynecology | 1984

A screening protocol for a prenatal population at risk for inherited hemoglobin disorders: Results of its application to a group of Southeast Asians and blacks

Janet Stein; Cynthia A. Berg; Judith A. Jones; James C. Detter

Several inherited hemoglobin disorders are present among certain racial subgroups of the United States population, particularly among blacks and Southeast Asians. Many of these disorders are unfamiliar to the obstetrician-gynecologist but may have important implications for care in pregnancy, including genetic counseling and prenatal diagnosis. A simple, effective screening tool was devised for detection of thalassemias and hemoglobinopathies in a prenatal clinic population. Use of the tool resulted in diagnosis of a hemoglobin disorder in 20% of a group of black patients; diagnoses included alpha-thalassemia trait, beta-thalassemia trait, hemoglobin C trait, hemoglobin S/C disease, hemoglobin S trait, sickle cell anemia, and hemoglobin Lepore. In a group of Southeast Asian patients, 39% had a hemoglobin disorder, including alpha-thalassemia trait, beta-thalassemia trait, hemoglobin E disease, and hemoglobin H disease. Implications for care are discussed.


Annals of Human Genetics | 1972

Genetic markers in chronic myelocytic leukaemia: evidence opposing autosomal inactivation and favouring 6-PGD-Rh linkage.

Philip J. Fialkow; R. Lisker; Eloise R. Giblett; C. Zavala; Azeydéh Cobo; James C. Detter

The possibility that there is random fixed inactivation a t autosomal loci, similar to that which effects major portions of the X chromosome, has been put forth by several workers (reviewed by Beutler, 1964). The best evidence in support of such an occurrence in autosomes is provided by the apparent inactivation of genes which control immuno-globulin synthesis (Pernis & Chiappino, 1964). Evidence against inactivation has been found for the loci controlling the synthesis of haemoglobin chains (Beutler, 1964) as well as the enzymes, lactate dehydrogenase, phosphoglucomutase,, and the branch chain amino acid decarboxylase (Davidson, Glen-Bott & Harris, 1965; Sigman & Gartler, 1966). The opportunity to look for inactivation a t several other autosomal loci was provided by the recent observation that chronic myelocytic leukaemia (CML) arises in a single marrow stem cell, i.e. the disease has a clonal origin (Fialkow, Gartler & Yoshida, 1967; Fialkow et al. 1969). Thus, one would expect that if a patient with CML were heterozygous a t any locus undergoing inactivation, that locus would have hemizygous expression in the CML cells but heterozygous expression in other tissues. A further advantage in studying CML patients is derived from the fact that their erythrocyte, granulocyte, and platelet precursors contain the Philadelphial (Phl) chromosome. This finding not only supports the concept of a clonal origin of CML, but also provides an opportunity to perform deletion mapping, since the Phl chromosome (number 22 (Caspersson et al. 1970)) lacks about 40 yo of its DNA. Thus, a hemizygous phenotype would also be observed in the CML cells of a heterozygote if the locus involved was situated on the deleted portion of the Phl chromosome and if that portion was not translocated onto another chromosome. In a previous paper (Fialkow et al. 1969) we reported finding a hemizygous 6-PGD phenotype in the CML cells of one patient whose cultured skin and inheritance studies both showed her to be heterozygous at the 6-PGD locus. Deletion was considered to be the most likely explanation. In this communication an extension of our previous study we provide data which support that deletion hypothesis and strengthen the suggestion of Weitkamp, Guttormsen & Greendyke (1969, 1970) that there is genetic linkage between the 6-PGD and Rh loci. In addition, our data demonstrate the absence of fixed inactivation a t a number of autosomal loci.


Blood | 1973

Recessive Familial Erythrocytosis: Aspects of Marrow Regulation in Two Families

John W. Adamson; George Stamatoyannopoulos; Stella Kontras; Andre Lascari; James C. Detter


American Journal of Clinical Pathology | 1979

Platelet Counts in Capillary Blood

James H. Feusner; Joyce A. Behrens; James C. Detter; Thomas C. Cullen


Kidney International | 1980

Physiologic studies in normal and uremic sheep: II. Changes in erythropoiesis and oxygen transport

Joseph W. Eschbach; James C. Detter; John W. Adamson


American Journal of Clinical Pathology | 1994

A NOVEL DELETION OF THE ENTIRE ALPHA GLOBIN LOCUS CAUSING ALPHA -THALASSEMIA-1 IN A NORTHERN EUROPEAN FAMILY

Daniel E. Sabath; James C. Detter; Jonathan F. Tait


American Journal of Clinical Pathology | 1979

Whole-blood hemoglobin determinations: a comparison of methodologies.

Joyce A. Behrens; Warren P. Brown; Donald F. Gibson; James C. Detter


Clinical Chemistry | 1976

Adaptation of the acid citrate--agar gel method for hemoglobin electrophoresis.

C N LeCrone; H K Broszeit; J A Jones; James C. Detter

Collaboration


Dive into the James C. Detter's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

C. Zavala

University of Washington

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Judith A. Jones

Harborview Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

R. Lisker

University of Washington

View shared research outputs
Top Co-Authors

Avatar

Azeydéh Cobo

University of Washington

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge